Antineoplastic, anti-metastatic and metabolic effects of newly synthesized platinum complexes

A. Biliuk, L. Garmanchuk, O. Skachkova, H. Repich, S. Orysyk
ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv; ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv; Ukrainian National Cancer Institute, Kiyv; Institute of general and inorganic chemistry of Natl. Acad. Sci. of Ukraine, Kiyv; Institute of general and inorganic chemistry of Natl. Acad. Sci. of Ukraine, Kiyv


The aim of this work was to study the antitumor, anti-metastatic and metabolic effects of the newly synthesized n, π-chelate complexes Pt2+ with N-allythioureas (complex II and IU complex). The studies used high-metastable strain of transfected Lewis lung carcinoma and HepG2-transformed hepatocyte cells with high activity gamma-glutamate transpeptidases and mouse leukemia cells of L1210 with pronounced aneuploid karyotype and short duplication of population. In the comparative analysis with the classical chemotherapy cisplatin, the II and IV complexes revealed antitumor and anti-metastatic effects and normalization of biochemical disorders, which are confirmed by a decrease in the activity of lactate
dehydrogenase and gamma-glutamine transpeptidase, indicating the inhibition of the formation of drug resistance.


n, π-chelate complexes Pt2 + with N-allylthioxides, antitumor and anti-metastatic action, gamaglutamintranspeptidase antiviability

Full Text:



Brandon M., Baldi P., Wallace D. Mitochondrial mutations in cancer // Oncogene. 2006; 25(34):4647–62.PMID:16892079DOI:10.1038/sj.onc.1209607

Hanigan M. Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance// Adv. Cancer. Res. 2014; 122: 103-41. PMID:24974180PMCID:PMC4388159DOI:10.1016/B978-0-12-420117-0.00003-7

Bui T., Nitta R., Kahn S., Razavi S., Agarwal M., Aujla P., Gholamin S., Recht L., Li G. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth // BMC Cancer. 2015; 15: 225-30doi: 10.1186/s12885-015-1232-y. MID:25884624PMCID:PMC4393868

Whitfield J. Gamma-glutamyltransferase // Crit Rev ClinLabSci. 2001;38 (4): P 263-355.PMID:11563810DOI:10.1080/20014091084227

Hanigan M., Frierson Immunohistochemical detection of gammaglutamyltranspeptidase

in normal human tissue // J HistochemCytochem. 1996; 44(10): 1101-8.PubMed: 8813074

Corti A., Franzini M., Paolicchi A., Pompella A. Gammaglutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting// Anticancer Research . 2010; 30:1169-82 PMID:20530424

Brière J., Favier J., Gimenez-Roqueplo A., Rustin P. Tricarboxylicacid cycledys functionas a cause of human diseases and tumor formation // Am. J. Physiol. Cell Physiol. 2006; 291:1114-20.PMID:16760265DOI:10.1152/ajpcell.00216.2006

Marín-Hernández A., Gallardo-Pérez J., Ralph S., Rodríguez-Enríquez S., Moreno-Sánchez R. HIF-1 alphamodulates energy metabolism in cancer cells by in ducing over-expression of specific glycolyticisoforms // MiniRev. Med. Chem. 2009; 9: 1084-101 PMID:19689405

Bilyuk A, Storozhuk O., Kolotiy O., Repich H., Orysyk S., Garmanchuk L. Pt (II) andPd (II) complexes in fluence on spheroids growth of breast cancer cells // Biotechnologia Acta. 2017;10(1): 61-7.

Kolotii Olga V., Biluk Anastasiya A., Storozhuk Olga V., Garmanchuk L. V. Impact of the new cisplatin analoguesπ-coordination complexes of Pt(ІІ) and Pd(II) on the growth dynamics of breast cancer spheroids // XV International Conference of. Students and Young Scientists "Shevchenkivska Vesna: BioScience Advances", 18-21.04.17

Repich H., Orysyk V., Palchykovska L, Orysyka S., Zborovskii Y., Vasylchenko O., Storozhuk O., Biluk A., Nikulina V., Garmanchuk L., Pekhnyo V., Vovk M. Synthesis, spectral characterization of novel Pd(II), Pt(II) π-coordination compounds based on

N-allylthioureas. Cytotoxic properties and DNA binding ability//Journal of Inorganic Biochemistry.2017;168: 98–110

Bilyuk A., Kolotiy O., Repich H., Orysyk V., Garmanchuk L. Рt (ii) and Рd (ii) complexes influence on GGT activity of breast cancer cells// Third International Biomedical School for Students, Postgraduates and Young Scientists on "Cellular Functions in Normal and Pathology" / / September 24-28, 2017

Bilyuk A., Negelie A., Skachkova O., Garmanchuk L. The activity of cytochrome oxidase and succinate dehydrogenase in the primary culture of Lewis lung transfectional carcinoma at different stages of tumor growth // Bulletin of the Taras Shevchenko National University of Kyiv. Problems of regulation of physiological functions. 2016; 21 (2):81-5

Kroemer G. Mitochondrion in cancer // Oncogene .2006;25: 4630-2PMID:16892077DOI10.1038/sj.onc.1209589

Fantin V., St-Pierre J., Leder P. Attenuationof LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance / // Cancer Cell.2006; 9:425-34PMID:16766262DOI:10.1016/j.ccr.2006.04.023

Mosmann T. Rapid colorimetricas say for cellular growth and survival: application to proliferation and cytotoxicity as says // Immunol. Methods. 1983;65(1–2):55–63PMID:6606682

Sen A., Dubey S., Squattrio P. Diaquabis(4-amino-3-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione)nickel(II) Nitrate: aSulfur-Nitrogen Chelate // ActaCryst. C. 1996;52: 865- 8.

Berridge M., Tan A. Characterization of the cellular reductionof 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT): subcellular localization, substrated ependence, and in volvemen to mitochondrial electron transportin MTT reduction // Arch. Biochem. Biophys.1993;303( 2.)474–82PMID:8390225DOI:10.1006/abbi.1993.1311

Kolev Y., Uetake H., Takagi Y., Sugihara K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis // Ann. Surg. Oncol. 2008;15:2336–344.]PMID: 18521687DOI:10.1245/s10434-008-9955-5

Javitt N. Hep G2 cellsas a resource for metabolic studies: lipoprotein, cholesterol, andbileacids. FASEB J.1990; 4:161–8 PMID:2153592

Aldred A., Cha M., Meckling-Gill K. Determination of a humane endpoint in the L1210 model of murine leukemia.Contemp Top Lab Anim Sci. 2002 Mar;41(2):24-7. PMID:11958599



  • There are currently no refbacks.

Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).